An Audit of Staphylococcus aureus Bacteraemia Treatment in a UK District General Hospital
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2017, Vol 7, Issue 4
Abstract
Objective: Recent guidelines from Healthcare Improvement Scotland recommend that uncomplicated Staphylococcus aureus bacteraemia (SAB) be treated with effective antibiotics for at least 14 days. This audit aimed to see whether Medway Hospital, UK, was following these guidelines, and whether a simple intervention could improve compliance and therefore treatment. Method: All patients with SAB between April 2013 and September 2014 were identified and their clinical notes, laboratory findings and drug charts were reviewed. Starting in January 2014 all SAB were reported on the online pathology results system with the following advice; ‘Staphylococcus aureus bacteraemia warrants a minimum of 14 days treatment. Treatment may be longer in cases of deep seated infection.’ Outcome measures included 14 days antimicrobial treatment, readmission rate with SAB, 3 month mortality post treatment and whether echocardiography was performed. Results: The demographics of all patients (35 pre and 39 post intervention) were comparable between groups (average age 63 vs 56, 54.3% vs 69.2% male) although the sources of bacteraemia differed slightly. More patients had indwelling lines in 2013 and there were a higher proportion of IV drug users in 2014; all other risk factors were similar between groups. More patients received appropriate antibiotics post intervention (74% vs 49%). Three month mortality with community acquired SAB increased but mortality with hospital acquired SAB decreased post intervention. Echocardiography uptake improved, and readmission rates with SAB decreased. Conclusion: The introduction of guidance with blood culture results has demonstrated better compliance with a 14 day minimum treatment length for SAB. Although sample size limits obtaining a statistically significant difference in readmission and mortality rates, this intervention still has the potential to improve treatment of SAB in aiding clinicians to follow guidelines. J Microbiol Infect Dis 2017; 7(4):188-193
Authors and Affiliations
Christine Scarsbrook, Nadeem Sajjad Raja, Michael Hardman, Kath Hughes
Keywords
Related Articles
- EP ID EP413785
- DOI 10.5799/jmid.369266
- Views 86
- Downloads 0
Akut Hepatit C Tedavisi
Akut Hepatit C virus (HCV) enfeksiyonu nadir görülen bir hastalıktır. Hastaların büyük bir kısmı asemptomatik seyretmektedir. HCV ile enfekte olan hastalar virüsü ya spontan olarak temizler veya kronik bir enf...
Correlates of adherence and utilization of Isoniazid preventive therapy in HIV patients
Objective: Isoniazid (INH) is given to individuals with latent infection of tuberculosis in order to prevent progression to active disease. It is important to understand factors associated with non-adherence to prophylac...
Pathogenic Vibrio Strains Isolated from Human Stool and Water Samples from Western Kenya
Objective: Investigate the type of pathogenic Vibrio strains from water and stool samples collected from Migori, SonduMiriu, Nyando and Yala regions in Western Kenya. Methods: A total of 811 samples (596 wate...
Preseptal and orbital cellulitis
Preseptal cellulitis (PC) is defined as an inflammation of the eyelid and surrounding skin, whereas orbital cellulitis (OC) is an inflammation of the posterior septum of the eyelid affecting the orbit and its contents. P...
A health care-associated pneumonia case due to colistin resistant Acinetobacter baumannii
A 78 year old male was hospitalized in neurology clinic with a diagnosis of encephalopathy. On 13th day of imipenem treatment for ventilator-associated pneumonia (VAP), a new VAP episode was diagnosed based on physical e...